ArticleBMC cancer2025

Comprehensive pan-cancer characterization of IRAK2 as a potential prognostic biomarker and therapeutic target with validation in hepatocellular carcinoma.

HaiJian Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.